English
Amplitude Surgical
ESEF2 filing records in this dataset, filed from 2022-11-17 to 2024-11-05. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 29.1 million EUR Source
Exact value
29101000 EUR
- Long-term debt including current maturities
- Not available
- Shares outstanding
- Not available
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2024-11-05.
Financial data available through: 2024-06-30.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 4 of 11 periods available· newest 2024-06-30
- Net income: 4 of 11 periods available· newest 2024-06-30
- Operating cash flow: 4 of 11 periods available· newest 2024-06-30
- Capital expenditure: 4 of 11 periods available· newest 2024-06-30
- Total assets: 4 of 11 periods available· newest 2024-06-30
- liabilities: No compatible figures in this window
- Current assets: 4 of 11 periods available· newest 2024-06-30
- Current liabilities: 4 of 11 periods available· newest 2024-06-30
- Cash and cash equivalents: 4 of 11 periods available· newest 2024-06-30
- long term debt: No compatible figures in this window
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
-96.1%Prior period
EUR 39.25 million
–
Current period
EUR 1.53 million
–
Exact inputs and evidence
1528000 − 39246000 = -37718000 EUR
39246000 EUR · 2022-07-01 – 2023-06-30
Inspect prior input Prior source1528000 EUR · 2023-07-01 – 2024-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-50.1%Prior period
EUR 8.1 million
–
Current period
EUR 4.04 million
–
Exact inputs and evidence
4043000 − 8096000 = -4053000 EUR
8096000 EUR · 2022-07-01 – 2023-06-30
Inspect prior input Prior source4043000 EUR · 2023-07-01 – 2024-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-7.1%Prior period
EUR 11.18 million
–
Current period
EUR 10.38 million
–
Exact inputs and evidence
10382000 − 11175000 = -793000 EUR
11175000 EUR · 2022-07-01 – 2023-06-30
Inspect prior input Prior source10382000 EUR · 2023-07-01 – 2024-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Values and sources
| Period | Series | Value(EUR) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2021 2020-07-01 – 2021-06-30 | −EUR 14.1 million Exact valueExact value: -14099000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | EUR 2.34 million Exact valueExact value: 2344000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | EUR 5.14 million Exact valueExact value: 5136000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | −EUR 2.79 million Calculation and evidence2344000 − 5136000 EUR Exact free cash flow: -2792000 EUR
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2021-07-01 – 2022-06-30 | −EUR 4.39 million Exact valueExact value: -4392000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | EUR 7.98 million Exact valueExact value: 7983000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | EUR 5.19 million Exact valueExact value: 5192000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | EUR 2.79 million Calculation and evidence7983000 − 5192000 EUR Exact free cash flow: 2791000 EUR
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2022-07-01 – 2023-06-30 | EUR 39.25 million Exact valueExact value: 39246000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | EUR 8.1 million Exact valueExact value: 8096000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | EUR 11.18 million Exact valueExact value: 11175000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | −EUR 3.08 million Calculation and evidence8096000 − 11175000 EUR Exact free cash flow: -3079000 EUR
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-07-01 – 2024-06-30 | EUR 1.53 million Exact valueExact value: 1528000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | EUR 4.04 million Exact valueExact value: 4043000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | EUR 10.38 million Exact valueExact value: 10382000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | −EUR 6.34 million Calculation and evidence4043000 − 10382000 EUR Exact free cash flow: -6339000 EUR
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
2 filings · 215 latest values · 215 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 9695006Q1VL1OHK06336, esef:9695006Q1VL1OHK06336